首页>
中文期刊>
《中国医学文摘:内科学分册(英文版)》
>Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novopatients with multiple myeloma
Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novopatients with multiple myeloma
Objective To explore the efficacy and safety of subcutaneous injection of bortezomib in the treatment of de novo multiple myeloma (MM) patients.Methods A total of 36 MM patients treated with bortezomib,adriamycin and dexamethason (PAD) from January 2012 to April2013 were analyzed.Among them,18 received improved PAD (improved PAD group) with the subcutaneous injection of bortezomib,another 18 received conventional PAD (PAD group) .The efficacy and safety of two groups
展开▼